Does BORTEZOMIB Cause Disseminated intravascular coagulation? 78 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Disseminated intravascular coagulation have been filed in association with BORTEZOMIB (bortezomib). This represents 0.2% of all adverse event reports for BORTEZOMIB.
78
Reports of Disseminated intravascular coagulation with BORTEZOMIB
0.2%
of all BORTEZOMIB reports
61
Deaths
42
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From BORTEZOMIB?
Of the 78 reports, 61 (78.2%) resulted in death, 42 (53.8%) required hospitalization, and 30 (38.5%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
Yes, Disseminated intravascular coagulation is listed as a known adverse reaction in the official FDA drug label for BORTEZOMIB.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which BORTEZOMIB Alternatives Have Lower Disseminated intravascular coagulation Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX